CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Egyptian Interntnl Phrmcticl Inds Co SAE is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Egyptian Interntnl Phrmcticl Inds Co SAE
EIPICO Building, Industrial Zone B1,
P.O. Box 149
Phone: +20 554499199p:+20 554499199 TENTH OF RAMADAN CITY, 44639  Egypt Ticker: PHARPHAR

Business Summary
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. EIPICO exports its products to Arab countries, as well as African, Asian and East European Countries. The Company’s products include anesthetics, analgesics, antibiotics, blood substitutes and restoratives, dermatological drugs and vitamins, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Managing Director Ahmed SaidMohamed Kelani 1/1/2019 1/1/2019
Non-Executive Member of the Board Fathi IbrahimAbdullah Ibrahim 3/1/2019 3/1/2019
Non-Executive Member of the Board Hamdi MahmoudAl Sayid Suleiman
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Egyptian Int'l Pharmaceutical Indusries
Egyptian Int'l Pharmaceutical Industries
Egyptian International Pharmaceutical Industrial Co.
EIPICO
PHAR
PHARM

General Information
Number of Employees: 2,039 (As of 12/31/2000)
Outstanding Shares: 148,755,750 (As of 12/31/2023)
Shareholders: 207
Stock Exchange: CAI
Fax Number: +20 554499306


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024